{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:55:26Z","timestamp":1790675726599,"version":"4.1.0"},"reference-count":21,"publisher":"Wiley","issue":"S2","license":[{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"vor","delay-in-days":25,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1111\/trf.70160","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:26:02Z","timestamp":1790411162000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ensuring quality in the community setting by leveraging accreditation"],"prefix":"10.1111","volume":"66","author":[{"given":"James Wade","family":"Atkins","sequence":"first","affiliation":[{"name":"National Institute of Health (NIH)  Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karishma","family":"Contractor","sequence":"additional","affiliation":[{"name":"Vertex Pharmaceuticals  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2354-4825","authenticated-orcid":false,"given":"Tracey","family":"Hlucky","sequence":"additional","affiliation":[{"name":"Kite Pharma, Inc., a Gilead Company  Santa Monica California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Wouters","sequence":"additional","affiliation":[{"name":"Blood Assurance, Inc.  Nashville Tennessee USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,26]]},"reference":[{"key":"e_1_2_16_2_1","unstructured":"Cell and gene therapy sector sees 30% investment surge despite market challenges\u2010BioSpace. (accessed 15 August 2025)."},{"key":"e_1_2_16_3_1","volume-title":"Title 21 CFR part 1271","author":"Code of Federal Regulations","year":"2025"},{"key":"e_1_2_16_4_1","volume-title":"Title 21 CFR part 211","author":"Code of Federal Regulations","year":"2025"},{"key":"e_1_2_16_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2019.04.002"},{"key":"e_1_2_16_6_1","volume-title":"Standards for cellular therapy services","author":"Brown K","year":"2025"},{"key":"e_1_2_16_7_1","volume-title":"Common standards for cellular therapies","author":"Foundation for the Accreditation of Cellular Therapy","year":"2023"},{"key":"e_1_2_16_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-75537-9_10"},{"key":"e_1_2_16_9_1","first-page":"1","volume-title":"Total quality management: key concepts and case studies","author":"Total Quality Management","year":"2017"},{"key":"e_1_2_16_10_1","volume-title":"Quality management system","author":"Quality Resources","year":"2024"},{"key":"e_1_2_16_11_1","volume-title":"AABB new assessor training","author":"Sloan M","year":"2022"},{"key":"e_1_2_16_12_1","volume-title":"WBMT workshop presented October 3\u20134, 2013, Salvador\u2010Bahia, Brazil","author":"Loper K","year":"2013"},{"key":"e_1_2_16_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010401"},{"key":"e_1_2_16_14_1","first-page":"287","volume-title":"Apheresis: principles and practice","author":"Kuker B","year":"2025"},{"key":"e_1_2_16_15_1","first-page":"177","volume-title":"Cellular therapy: principles, methods, and regulations","author":"Keever\u2010Taylor CA","year":"2016"},{"key":"e_1_2_16_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2019.05.008"},{"key":"e_1_2_16_17_1","unstructured":"AABB Accreditation. Available athttps:\/\/www.aabb.org\/standards-accreditation(accessed 07\/21\/2025)."},{"key":"e_1_2_16_18_1","unstructured":"FACT Accreditation. Available athttps:\/\/www.factglobal.org\/accreditation-process\/(accessed 07\/21\/2025)."},{"key":"e_1_2_16_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2024.09.006"},{"key":"e_1_2_16_20_1","unstructured":"PittosEC RichardsRE BillupsR.Is community the next frontier for cell and gene therapy?PharmExec.com; 2025. Available athttps:\/\/www.pharmexec.com\/view\/community-next-frontier-cell-gene-therapy"},{"key":"e_1_2_16_21_1","unstructured":"FDA guidance for industry: considerations for the development of chimeric antigen receptor (CAR) T cell products; 2024. Available athttps:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/considerations-development-chimeric-antigen-receptor-car-t-cell-products"},{"key":"e_1_2_16_22_1","volume-title":"Apheresis: principles and practice","author":"Jones BC","year":"2025"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.70160","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/trf.70160","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.70160","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:00:16Z","timestamp":1790672416000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.70160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":21,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1111\/trf.70160"],"URL":"https:\/\/doi.org\/10.1111\/trf.70160","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"2025-09-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}